Recap: Treace Medical Concepts Q4 Earnings
Portfolio Pulse from Benzinga Insights
Treace Medical Concepts (NASDAQ:TMCI) reported Q4 earnings with an EPS of $-0.1, missing estimates by -11.0%. Revenue increased by $12.44 million from the previous year. The company had previously experienced a 38.0% share price drop after missing EPS estimates last quarter.
February 27, 2024 | 9:35 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Treace Medical Concepts reported a Q4 EPS of $-0.1, missing estimates by -11.0%, with a revenue increase of $12.44 million from the previous year.
Given TMCI's history of a significant stock price drop following an earnings miss last quarter, the current earnings miss may similarly lead to a short-term negative impact on the stock price. The revenue increase might mitigate some negative sentiment, but the focus on missed EPS could dominate investor reactions.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100